Study bridges a divide in cell aging in neurodegenerative diseases

Study bridges a divide in cell aging in neurodegenerative diseases
From left, doctoral students Amanda Hall and Lauren Ostrowski and Associate Professor Karim Mekhail. Credit: Jim Oldfield

Research from the University of Toronto has shown that in some neurodegenerative diseases, two hallmarks of cell aging – protein aggregation and a type of DNA instability – are linked. They were previously thought to be unconnected.

The researchers used cellular models of amyotrophic lateral sclerosis (ALS) and and found that the gumming up of certain proteins undermines the stability of ribosomal DNA repeats – repetitive genetic sequences essential for manufacturing all proteins and cells.

"We found that shorten the lifespan of the cell by compromising the stability of the highly repetitive ribosomal DNA sequences," says Karim Mekhail, an associate professor in the Faculty of Medicine's department of laboratory medicine and pathobiology who holds the Canada Research Chair in Spatial Genome Organization.

"That these two major mechanisms of cell aging are connected points to strategies that may hit two birds with one stone in neurodegeneration."

The journal Communications Biology published the results earlier this month.

Repetitive DNA sequences comprise over half of the genome in some organisms, and they are essential to cell function. But they are susceptible to reorganization, which can lead to chromosomal rearrangements, premature cell aging and disease.

Mekhail and his team, including doctoral students Lauren Ostrowski and Amanda Hall, first found that trouble-making proteins – which emerge from repetitive DNA sequences called transposons – aggregate in humanized with mutations found in patients suffering from ALS and ataxia. They then mapped how the aggregates destabilize ribosomal DNA repeats and lead to premature yeast cell aging, before confirming the findings in human .

The work took more than four years. "This story was full of surprises," says Mekhail. "The findings may seem obvious in retrospect, but if you'd told us in the beginning that there was crosstalk between aggregation and destabilization of DNA, we'd have thought that was absurd. Lauren and Amanda really had to persevere."

To identify new and urgently needed therapeutic approaches, the are now testing if drugs that disrupt transposon protein aggregates restore genome stability and cell lifespan in various neurodegenerative diseases.

Explore further

DNA 'off switch' may reverse premature aging

More information: Lauren A. Ostrowski et al. Conserved Pbp1/Ataxin-2 regulates retrotransposon activity and connects polyglutamine expansion-driven protein aggregation to lifespan-controlling rDNA repeats, Communications Biology (2018). DOI: 10.1038/s42003-018-0187-3
Citation: Study bridges a divide in cell aging in neurodegenerative diseases (2018, November 21) retrieved 27 February 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments